DLB
Dolby Laboratories, Inc. NYSE Listed Feb 17, 2005$57.45
Mkt Cap $5.5B
52w Low $55.73
7.6% of range
52w High $78.28
50d MA $62.16
200d MA $66.80
P/E (TTM)
21.6x
EV/EBITDA
16.6x
P/B
2.1x
Debt/Equity
0.0x
ROE
9.3%
P/FCF
16.1x
RSI (14)
—
ATR (14)
—
Beta
0.86
50d MA
$62.16
200d MA
$66.80
Avg Volume
685.3K
Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, DTV, transmissions and devices, mobile devices, OTT video and music services, and home entertainment devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications.; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, an digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and a range of media devices. Its audio technologies also include Dolby Digital, a digital audio coding technology that provides multichannel sound to applications; Dolby Digital Plus, a digital audio coding technology that offers audio transmission for a range of media applications and devices; Dolby TrueHD, a digital audio coding technology providing encoding for media application; Dolby Vision, an imaging technology for cinema and media devices; Dolby Voice, an audio conferencing technology; and HEVC, a digital video codec with high bandwidth efficiency to support for media devices. In addition, the company designs and manufactures digital cinema servers, cinema processors, amplifiers, loudspeakers, hardware components, video conferencing solutions, and other products for the cinema, television, broadcast, communication, and entertainment industries. Further, it offers various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. The company serves film studios, content creators, post-production facilities, cinema operators, broadcasters, and video game designers. It sells its products directly to the end users, as well as through dealers and distributors worldwide. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.
1275 Market Street · San Francisco, CA 94103-1410 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | 1.31 | 1.37 | +4.6% | 64.14 | -6.4% | -10.4% | +1.7% | +1.1% | -1.8% | -0.9% | — |
| Jan 29, 2026 | AMC | 0.99 | 1.06 | +6.7% | 63.03 | -0.4% | +1.8% | +0.5% | -5.3% | +5.6% | -0.8% | — |
| Nov 18, 2025 | AMC | 0.70 | 0.99 | +41.6% | 64.96 | -1.2% | +0.1% | +0.8% | +3.0% | -1.1% | +0.9% | — |
| Jul 31, 2025 | AMC | 0.71 | 0.78 | +9.2% | 75.34 | -3.0% | -7.0% | +3.3% | +0.3% | -0.3% | -0.5% | — |
| May 1, 2025 | AMC | 1.27 | 1.34 | +5.5% | 76.18 | -4.3% | -1.7% | -0.2% | -0.6% | -1.1% | +2.1% | — |
| Jan 29, 2025 | AMC | 1.12 | 1.14 | +1.8% | 80.63 | +2.9% | +8.3% | -4.1% | +0.5% | +0.3% | +0.1% | — |
| Nov 19, 2024 | AMC | 0.70 | 0.81 | +15.7% | 70.91 | +6.5% | +15.6% | -2.1% | +0.4% | -0.3% | +0.0% | — |
| Aug 7, 2024 | AMC | 0.30 | 0.71 | +132.8% | 73.22 | -1.5% | -7.2% | -0.6% | -1.2% | +4.0% | +1.0% | — |
| May 2, 2024 | AMC | 1.19 | 1.27 | +6.7% | 79.71 | +2.1% | +3.0% | -0.1% | +1.1% | -0.4% | +0.2% | — |
| Feb 1, 2024 | AMC | 0.53 | 1.01 | +90.2% | 84.82 | -1.4% | -5.4% | -1.6% | +0.5% | -0.2% | +1.9% | — |
| Nov 16, 2023 | AMC | 0.22 | 0.65 | +193.5% | 87.77 | -8.2% | -7.1% | +2.6% | +1.6% | +2.0% | -0.2% | — |
| Aug 3, 2023 | AMC | 0.28 | 0.55 | +98.0% | 87.84 | -1.8% | -9.8% | -0.4% | -1.7% | -0.6% | -0.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 | Barrington Research | Maintains | Outperform → Outperform | — | $64.08 | $64.02 | -0.1% | -0.7% | -1.1% | +0.5% | +1.4% | -10.4% |
| Jan 30 | Barrington Research | Maintains | Outperform → Outperform | — | $63.03 | $62.80 | -0.4% | +1.8% | +0.5% | -5.3% | +5.6% | -0.8% |
| Jan 30 | Rosenblatt | Maintains | Buy → Buy | — | $63.03 | $62.80 | -0.4% | +1.8% | +0.5% | -5.3% | +5.6% | -0.8% |
| Jan 26 | Barrington Research | Maintains | Outperform → Outperform | — | $62.05 | $62.33 | +0.5% | +0.1% | -1.2% | -0.3% | +3.0% | +1.8% |
| Jan 22 | Rosenblatt | Maintains | Buy → Buy | — | $62.15 | $62.45 | +0.5% | +0.9% | -1.0% | +0.1% | -1.2% | -0.3% |
| Nov 19 | Rosenblatt | Maintains | Buy → Buy | — | $64.96 | $64.15 | -1.2% | +0.1% | +0.8% | +3.0% | -1.1% | +0.9% |
| Nov 19 | Barrington Research | Maintains | Outperform → Outperform | — | $64.96 | $64.15 | -1.2% | +0.1% | +0.8% | +3.0% | -1.1% | +0.9% |
| Sep 12 | Barrington Research | Maintains | Outperform → Outperform | — | $72.11 | $72.24 | +0.2% | -0.9% | +0.5% | +0.1% | -0.6% | +0.9% |
| Aug 15 | Tigress Financial | Maintains | Buy → Buy | — | $72.53 | $72.60 | +0.1% | +0.4% | +1.4% | +0.0% | -0.5% | -0.8% |
| Aug 1 | Rosenblatt | Maintains | Buy → Buy | — | $75.34 | $73.07 | -3.0% | -7.0% | +3.3% | +0.3% | -0.3% | -0.5% |
| Jun 13 | Rosenblatt | Maintains | Buy → Buy | — | $75.23 | $74.95 | -0.4% | -1.6% | +1.6% | -1.5% | -1.0% | -1.4% |
| May 15 | Tigress Financial | Maintains | Buy → Buy | — | $76.95 | $76.84 | -0.1% | +0.4% | +0.4% | -0.8% | -0.1% | -1.4% |
| May 2 | Rosenblatt | Maintains | Buy → Buy | — | $76.18 | $72.88 | -4.3% | -1.7% | -0.2% | -0.6% | -1.1% | +2.1% |
| May 2 | Barrington Research | Maintains | Outperform → Outperform | — | $76.18 | $72.88 | -4.3% | -1.7% | -0.2% | -0.6% | -1.1% | +2.1% |
| Feb 13 | Barrington Research | Maintains | Outperform → Outperform | — | $82.98 | $83.70 | +0.9% | +1.6% | -0.6% | +0.9% | -1.3% | -1.3% |
| Jan 30 | Rosenblatt | Maintains | Buy → Buy | — | $80.63 | $83.00 | +2.9% | +8.3% | -4.1% | +0.5% | +0.3% | +0.1% |
| Jan 30 | Barrington Research | Maintains | Outperform → Outperform | — | $80.63 | $83.00 | +2.9% | +8.3% | -4.1% | +0.5% | +0.3% | +0.1% |
| Jan 27 | Barrington Research | Maintains | Outperform → Outperform | — | $79.71 | $79.71 | +0.0% | +1.7% | -0.6% | +0.0% | +8.3% | -4.1% |
| Jan 23 | Rosenblatt | Maintains | Buy → Buy | — | $80.96 | $80.87 | -0.1% | -0.6% | -0.9% | +1.7% | -0.6% | +0.0% |
| Nov 20 | Rosenblatt | Maintains | Buy → Buy | — | $70.91 | $75.50 | +6.5% | +15.6% | -2.1% | +0.4% | -0.3% | +0.0% |
| Nov 20 | Barrington Research | Maintains | Outperform → Outperform | — | $70.91 | $75.50 | +6.5% | +15.6% | -2.1% | +0.4% | -0.3% | +0.0% |
| Sep 20 | Barrington Research | Maintains | Outperform → Outperform | — | $72.61 | $72.75 | +0.2% | +0.9% | -0.6% | +2.0% | +0.9% | +1.1% |
| Aug 9 | Barrington Research | Maintains | Outperform → Outperform | — | $67.96 | $68.43 | +0.7% | -0.6% | -1.2% | +4.0% | +1.0% | +2.4% |
| Jun 7 | Rosenblatt | Maintains | Buy → Buy | — | $80.01 | $79.73 | -0.3% | -0.8% | -0.3% | +0.2% | -0.3% | -1.4% |
| Jun 3 | Barrington Research | Upgrade | Market Perform → Outperform | — | $81.01 | $81.79 | +1.0% | -0.3% | -0.3% | -0.8% | +0.1% | -0.8% |
| May 3 | Rosenblatt | Maintains | Buy → Buy | — | $79.71 | $81.38 | +2.1% | +3.0% | -0.1% | +1.1% | -0.4% | +0.2% |
| Apr 29 | Rosenblatt | Maintains | Buy → Buy | — | $79.20 | $79.59 | +0.5% | +0.2% | -2.2% | -0.1% | +2.7% | +3.0% |
| Jan 31 | Rosenblatt | Maintains | Buy → Buy | — | $84.66 | $84.44 | -0.3% | -1.7% | +2.0% | -5.4% | -1.6% | +0.5% |
| Dec 11 | Rosenblatt | Maintains | Buy → Buy | — | $89.38 | $89.46 | +0.1% | -0.0% | -0.6% | -0.8% | +0.6% | -1.3% |
| Nov 17 | Rosenblatt | Maintains | Buy → Buy | — | $87.77 | $80.55 | -8.2% | -7.1% | +2.6% | +1.6% | +2.0% | -0.2% |
| Aug 4 | Rosenblatt | Maintains | Buy → Buy | — | $87.84 | $86.30 | -1.8% | -9.8% | -0.4% | -1.7% | -0.6% | -0.3% |
| Jul 28 | Rosenblatt | Maintains | Buy → Buy | — | $87.69 | $88.14 | +0.5% | +0.8% | +0.2% | +0.3% | -1.1% | -0.0% |
| Jun 1 | Rosenblatt | Maintains | Buy → Buy | — | $82.53 | $82.14 | -0.5% | -0.8% | +1.9% | -0.8% | +0.3% | -0.0% |
| Apr 26 | Rosenblatt | Maintains | Buy → Buy | — | $82.43 | $82.54 | +0.1% | -0.6% | +1.7% | +0.4% | -0.3% | -1.2% |
| Apr 14 | Tigress Financial | Maintains | Buy → Buy | — | $85.91 | $85.65 | -0.3% | -0.4% | +0.1% | +0.2% | -0.5% | -0.4% |
| Feb 3 | Rosenblatt | Maintains | Buy → Buy | — | $82.67 | $85.00 | +2.8% | +4.5% | -2.9% | +1.1% | -0.7% | -0.3% |
| Nov 18 | Barrington Research | Downgrade | Outperform → Market Perform | — | $69.75 | $67.37 | -3.4% | -1.0% | -1.2% | +1.9% | +2.5% | +1.1% |
| Nov 7 | Rosenblatt | Maintains | Buy → Buy | — | $66.90 | $66.60 | -0.4% | -0.5% | +0.9% | -1.2% | +4.9% | +1.1% |
| Oct 14 | Tigress Financial | Maintains | Buy → Buy | — | $64.70 | $65.27 | +0.9% | -0.6% | +2.2% | +0.4% | -0.9% | -0.2% |
| Aug 26 | Rosenblatt | Maintains | Buy → Buy | — | $77.10 | $77.00 | -0.1% | -4.7% | +0.9% | -0.5% | -0.7% | +0.3% |
| May 24 | Rosenblatt | Maintains | Buy → Buy | — | $75.34 | $75.22 | -0.2% | -1.9% | +1.7% | +1.3% | +2.8% | -0.9% |
| Aug 2 | Barrington Research | Upgrade | Market Perform → Outperform | — | $97.10 | $98.60 | +1.5% | +2.8% | -0.1% | -2.6% | +0.8% | +0.3% |
| Jan 29 | B. Riley FBR | Maintains | Neutral → Neutral | — | $89.20 | $89.90 | +0.8% | -1.3% | +1.5% | +2.0% | -0.0% | +0.8% |
| Jan 29 | B. Riley Securities | Maintains | Neutral → Neutral | — | $89.20 | $89.90 | +0.8% | -1.3% | +1.5% | +2.0% | -0.0% | +0.8% |
| Jan 28 | B. Riley FBR | Maintains | Neutral → Neutral | — | $86.59 | $87.74 | +1.3% | +3.0% | -1.3% | +1.5% | +2.0% | -0.0% |
| Jun 24 | B. Riley FBR | Downgrade | Buy → Neutral | — | $68.05 | $66.49 | -2.3% | -3.0% | +0.4% | -0.7% | +0.5% | -0.4% |
| Jun 24 | B. Riley Securities | Downgrade | Buy → Neutral | — | $68.05 | $66.49 | -2.3% | -3.0% | +0.4% | -0.7% | +0.5% | -0.4% |
| May 5 | JP Morgan | Maintains | Overweight → Overweight | — | $58.52 | $55.90 | -4.5% | -5.8% | -0.1% | +3.1% | +2.2% | -0.4% |
| May 5 | B. Riley Securities | Maintains | Buy → Buy | — | $58.52 | $55.90 | -4.5% | -5.8% | -0.1% | +3.1% | +2.2% | -0.4% |
| May 5 | B. Riley FBR | Maintains | Buy → Buy | — | $58.52 | $55.90 | -4.5% | -5.8% | -0.1% | +3.1% | +2.2% | -0.4% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | Couling John D | SVP, Entertainment | Sell | 738 | $58.34 | $43K | 118,353 | -0.88% | — |
| May 5, 2026 | Couling John D | SVP, Entertainment | Sell | 6,928 | $57.47 | $398K | 119,091 | -0.88% | — |
| May 4, 2026 | Couling John D | SVP, Entertainment | Sell | 4,688 | $58.47 | $274K | 118,353 | -0.88% | — |
8-K
Dolby Laboratories, Inc. -- 8-K Filing
Dolby Laboratories is reminding investors to monitor its official public disclosure channels, as information released through multiple platforms may constitute material information affecting the stock price.
Apr 30
8-K
Dolby Laboratories, Inc.Class A -- 8-K Filing
Dolby Laboratories filed a Form 8-K indicating a material event or corporate action requiring disclosure to shareholders and the market.
Feb 6
Data updated apr 25, 2026 5:20am
· Source: massive.com